Enhanced Apc Min/+ adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells

Beibei Guo,Yawen Zheng,Yujia Fan,Yang Yang,Yuxing Wang,Liping Qin,Yachun An,Xiaoran Xu,Xiyu Zhang,Gongping Sun,Hao Dou,Changshun Shao,Yaoqin Gong,Baichun Jiang,Huili Hu

DOI: https://doi.org/10.1016/j.neo.2024.101005

IF: 6.218

2024-05-19

Neoplasia

Abstract:Colorectal cancer (CRC) stands as a prevalent malignancy globally. A pivotal event in CRC pathogenesis involves the loss-of-function mutation in the APC gene, leading to the formation of benign polyps. Despite the well-established role of APC , the contribution of CUL4B to CRC initiation in the pre-tumorous stage remains poorly understood. In this investigation, we generated a murine model by crossing Apc Min/+ mice with Cul4b ΔIEC mice to achieve specific deletion of Cul4b in the gut epithelium against an Apc Min/+ background. By employing histological methods, RNA-sequencing (RNA-seq), and flow cytometry, we assessed alterations and characterized the immune microenvironment. Our results unveiled that CUL4B deficiency in gut epithelium expedited Apc Min/+ adenoma formation. Notably, CUL4B in adenomas restrained the accumulation of tumor-infiltrating myeloid-derived suppressor cells (MDSCs). In vivo inhibition of MDSCs significantly delayed the growth of CUL4B deleted Apc Min/+ adenomas. Furthermore, the addition of MDSCs to in vitro cultured Apc Min/+ ; Cul4b ΔIEC adenoma organoids mitigated their alterations. Mechanistically, CUL4B directly interacted with the promoter of Csf3 , the gene encoding granulocyte-colony stimulating factor (G-CSF) by coordinating with PRC2. Inhibiting CUL4B epigenetically activated the expression of G-CSF, promoting the recruitment of MDSCs. These findings offer novel insights into the tumor suppressor-like roles of CUL4B in regulating Apc Min/+ adenomas, suggesting a potential therapeutic strategy for CRC initiation and progression in the context of activated Wnt signaling.

oncology